13F HOLDINGS REPORT
Checkpoint Capital L.P.
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001977548-24-000007
Total Value
$165.9M
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | RHYTHM PHARMACEUTICALS INC | RYTM | 922,100 | $37.9M | 22.82% |
| 2 | ARGENX SE | ARGX | 82,150 | $35.3M | 21.30% |
| 3 | AXSOME THERAPEUTICS INC | AXSM | 290,772 | $23.4M | 14.11% |
| 4 | AVADEL PHARMACEUTICALS PLC | G29687103 | 1,138,178 | $16.0M | 9.65% |
| 5 | PROTAGONIST THERAPEUTICS INC | PTGX | 355,000 | $12.3M | 7.42% |
| 6 | CYTOKINETICS INC | CYTK | 190,000 | $10.3M | 6.21% |
| 7 | PHATHOM PHARMACEUTICALS INC | PHAT | 875,000 | $9.0M | 5.43% |
| 8 | CORCEPT THERAPEUTICS INC | CORT | 244,750 | $8.0M | 4.79% |
| 9 | ATYR PHARMA INC | ATYR | 1,946,477 | $3.0M | 1.83% |
| 10 | PLIANT THERAPEUTICS INC | PLRX | 232,200 | $2.5M | 1.50% |
| 11 | KYMERA THERAPEUTICS INC | KYMR | 82,000 | $2.4M | 1.48% |
| 12 | CIDARA THERAPEUTICS INC | 171757206 | 145,417 | $1.7M | 1.05% |
| 13 | TREVI THERAPEUTICS INC | TRVI | 500,089 | $1.5M | 0.90% |
| 14 | APPLIED THERAPEUTICS INC | 03828A101 | 227,470 | $1.1M | 0.64% |
| 15 | SOLENO THERAPEUTICS INC | SLNO | 19,695 | $803,556 | 0.48% |
| 16 | ALLAKOS INC | 01671P100 | 649,957 | $649,957 | 0.39% |